TA’SIRLANGAN ICHAK SINDROMIDA VITSERAL SEZUVCHANLIK INDEKSI VA ULARDA SISTEMATIK DESENSIBILIZATSIYA TERAPIYASINING SAMARADORLIGI
##article.subject##:
ta’sirlangan ichak sindromi, vitseral sezuvchanlik indeksi, sistematik desensibilizatsiya, ratsional psixoterapiya, sulpirid, xavotir-fobik buzilishlar##article.abstract##
Mazkur tadqiqotda ta’sirlangan ichak sindromi bilan kasallangan 80 nafar bemorda vitseral sezuvchanlik indeksi va sistematik desensibilizatsiya terapiyasining samaradorligi o‘rganildi. Bemorlar 2 guruhga ajratildi: 1-guruhga sistematik desensibilizatsiya terapiyasi va sulpirid, 2-guruhga ratsional psixoterapiya va sulpirid qo‘llanildi. Tadqiqot natijalari sistematik desensibilizatsiya terapiyasi vitseral sezuvchanlik ko‘rsatkichlari hamda xavotir-fobik simptomlarni kamaytirishda samarali ekanligini ko‘rsatdi.
Библиографические ссылки
Маев И.В., Охлобыстина О.З., Халиф И.Л., Андреев Д.Н. Синдром раздраженного кишечника в Российской Федерации – результаты многоцентрового наблюдательного исследования ROMERUS // Терапевтический архив. 2023. Т. 95, № 1. С. 38–51. DOI: 10.26442/00403660.2023.01.202043. PMID: 37167114.
Axelsson E., et al. Psychological treatments for irritable bowel syndrome: comprehensive systematic review and meta-analysis // Cognitive Behaviour Therapy. 2023. DOI: 10.1080/16506073.2023.2225745.
Breeman S., Cotton S., Fielding S., Jones G.T. Normative data for the Hospital Anxiety and Depression Scale // Quality of Life Research. 2015. Vol. 24, No. 2. P. 391–398. DOI: 10.1007/s11136-014-0763-z.
Gafurova S. S., Sharodiya D., Alimuhamedova S. J. TO IDENTIFY ANXIETY-PHOBIC DISORDERS IN IRRITABLE BOWEL SYNDROME AND STUDY THE EFFECTIVENESS OF COGNITIVE BEHAVIORAL THERAPY IN THEM. – 2025.
Gafurova S. S., Yusuphadjaeva S. T. ANXIETY-PHOBIC DISORDERS IN IRRITABLE BOWEL SYNDROME AND THE
EFFECTIVENESS OF PSYCHOTHERAPY AND PSYCHOPHARMACOTHERAPY //International Bulletin of Medical Sciences and Clinical Research. – 2023. – Т. 3. – №. 1. – С. 110-115.
Creed F. Review article: the incidence and risk factors for irritable bowel syndrome in population-based studies // Alimentary Pharmacology & Therapeutics. 2019. Vol. 50, No. 5. P. 507–516.
Drossman D.A. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV // Gastroenterology. 2016. Vol. 150, No. 6. P. 1262–1279.
Everitt H.A., Landau S., O‘Reilly G., et al. Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial // The Lancet Gastroenterology & Hepatology. 2019. Vol. 4, No. 11. P. 863–872.
Hanlon I., Hewitt C., Bell K., Phillips A., Mikocka-Walus A. Online psychological interventions in GI disorders including TIS: systematic review and meta-analysis // Alimentary Pharmacology & Therapeutics. 2018. Vol. 48, No. 3. P. 244–259. DOI: 10.1111/apt.14840.
Palsson O.S. Hypnosis Treatment of Gastrointestinal Disorders: A Comprehensive Review of the Empirical Evidence // American Journal of Clinical Hypnosis. 2015. Vol. 58, No. 2. P. 134–158.
